CagriSema

Cagrilintide + Semaglutide (CagriSema)

AI explanation

CagriSema is a revolutionary weight loss medication that combines two powerful appetite-controlling drugs into one weekly injection. People use it because it's incredibly effective at helping them lose weight by making them feel full and satisfied with much smaller portions of food.

Think of your brain as having two separate "fullness sensors" that normally tell you when to stop eating. Most weight loss medications only target one of these sensors, but CagriSema is like flipping both switches at once. The first part, semaglutide, mimics a hormone called GLP-1 that your intestines naturally release when you eat. It tells your brain "we're getting fed" and slows down how quickly food leaves your stomach, so you stay satisfied longer.

The second part, cagrilintide, works completely differently by copying amylin, a hormone your pancreas releases alongside insulin. While GLP-1 works through your gut, amylin speaks directly to different areas of your brain's appetite control center. It's like having two independent security guards both saying "kitchen's closed" instead of just one.

When these two systems work together, they create a much stronger feeling of fullness than either could alone. Your body essentially gets a double message that it's well-fed, making it much easier to eat appropriate portions without feeling deprived or fighting constant hunger.

Dosage Information

Typical Dose

2.4 mg semaglutide + 2.4 mg cagrilintide

Frequency

Once weekly

Anytime

Administration

Subcutaneous injection

Half-Life

7 days

Notes

Fixed-dose combination in a single prefilled pen. NDA submitted December 2025.

Why this matters

Combination of semaglutide and cagrilintide; once-weekly injection.

Dose Calculator

Calculate your draw amount for an insulin syringe (U-100)

Concentration: 2,500 mcg/mL

Sign in to save your reconstitution settings for this peptide

Draw to the

96

unit mark

020406080100

Draw 96 units for your 2400mcg dose of CagriSema

This calculator is for educational purposes. Always verify your calculations and consult a healthcare professional.

Where does CagriSema sit?

See how this peptide compares across all 150 peptides in our database.

Potential Side Effects

NauseaDiarrheaVomitingConstipationInjection site reactions
Pep Talk

CagriSema discussions

Quick Facts

Administration
Subcutaneous injection
Typical Dose
2.4 mg semaglutide + 2.4 mg cagrilintide
Frequency
Once weekly
References
1 curated + 0 from PubMed

Frequently Asked Questions about CagriSema

What is CagriSema?

CagriSema is a combination therapy from Novo Nordisk pairing semaglutide (GLP-1 agonist) with cagrilintide (long-acting amylin analog) in a single weekly injection. It targets two independent satiety pathways for enhanced weight loss.

How does CagriSema work?

Dual-mechanism approach combining GLP-1 receptor activation (semaglutide) with amylin receptor agonism (cagrilintide). Amylin is a hormone co-released with insulin that signals satiety through pathways completely independent of GLP-1. Activating both produces additive appetite suppression and metabolic improvement.

What is the recommended dosage for CagriSema?

The typical dose is 2.4 mg semaglutide + 2.4 mg cagrilintide. Once weekly. Administration: Subcutaneous injection. Fixed-dose combination in a single prefilled pen. NDA submitted December 2025.

What are the side effects of CagriSema?

Nausea. Diarrhea. Vomiting. Constipation. Injection site reactions

Questions reflect common community inquiries. This is not medical advice.